Advancing iPSC Innovation at the ISSCR 2025

We’re excited to share that uBriGene will be exhibiting at the ISSCR 2025 Annual Meeting, happening June 11–14 at the Hong Kong Convention and Exhibition Centre.

As one of the leading global conferences in stem cell research and regenerative medicine, ISSCR brings together top scientists, innovators, and industry leaders to explore the latest advancements shaping the future of healthcare.

At Booth #907, uBriGene will showcase how we’re helping bridge cell and gene therapies from concept to commercialization. Our team will highlight the technologies and manufacturing platforms powering the next wave of stem cell and RNA-based innovations—from iPSC development to scalable GMP production. We’re especially focused on how integrated CDMO services like ours can help biotech developers and researchers streamline their path to the clinic.

We’re also proud to be presenting two new scientific posters at ISSCR this year:

1) Poster #T1359 - Characterization of GMP-Compliant Induced Pluripotent Stem Cell (iPSC) Master Cell Bank for Clinical Applications

2) Poster #T1192 -  An Innovative mRNA-LNP Kit for iPSC Reprogramming from PBMC

📅 4PM and 5 PM on June 12, 2025 at the Exhibit & Poster Hall (3BCDE, Level 3).

At uBriGene, we’re committed to making advanced therapies more accessible by delivering high-quality, scalable, and innovative manufacturing solutions. Whether you're developing stem cell therapies, mRNA therapeutics, or complex biologics, we’re here to be your partner from discovery to delivery.

We look forward to seeing you in Hong Kong—stop by Booth #907 to meet our team and explore how we can support your next breakthrough.

Learn more about the event at ISSCR 2025 Annual Meeting